Antwerp, Belgium

Jan Willem Thuring


 

Average Co-Inventor Count = 10.4

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Hamden, CT (US) (2004 - 2005)
  • Antwerp, BE (2005 - 2021)

Company Filing History:


Years Active: 2004-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jan Willem Thuring: Innovator in Pharmaceutical Research

Introduction

Jan Willem Thuring is a notable inventor based in Antwerp, Belgium. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of five patents to his name, Thuring's work has the potential to impact various medical conditions.

Latest Patents

Thuring's latest patents include innovative pyrazole derivatives that serve as MALT1 inhibitors. These compounds, compositions, and methods are designed for the treatment of diseases, syndromes, conditions, and disorders influenced by the modulation of MALT1. The compounds are represented by specific formulas, which detail the structural components involved in their efficacy.

Career Highlights

Throughout his career, Jan Willem Thuring has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bristol-Myers Squibb Company and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Thuring has collaborated with esteemed colleagues in his field, including Kuo-Long Yu and Xiangdong Alan Wang. These partnerships have facilitated the exchange of ideas and advancements in pharmaceutical innovations.

Conclusion

Jan Willem Thuring's contributions to pharmaceutical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…